361550 Sigma-AldrichGSK-3 Inhibitor IX - CAS 667463-62-9 - Calbiochem
BIO, CAS 667463-62-9, is a cell-permeable, highly potent, selective, reversible, and ATP-competitive inhibitor of GSK-3α/β (IC₅₀ = 5 nM). Maintains self-renewal in human & mouse embryonic stem cells.
More>> BIO, CAS 667463-62-9, is a cell-permeable, highly potent, selective, reversible, and ATP-competitive inhibitor of GSK-3α/β (IC₅₀ = 5 nM). Maintains self-renewal in human & mouse embryonic stem cells. Less<<Synonyms: BIO, (2ʹZ,3ʹE)-6-Bromoindirubin-3ʹ-oxime
Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
667463-62-9 | C₁₆H₁₀BrN₃O₂ |
Pricing & Availability
Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
---|---|---|---|---|---|---|
361550-10MGCN |
|
Plastic ampoule | 10 mg |
|
— | |
361550-1MGCN |
|
Plastic ampoule | 1 mg |
|
— | |
361550-30MGCN |
|
Plastic ampoule | 30 mg |
|
— |
Description | |
---|---|
Overview | A cell-permeable bis-indolo (indirubin) compound that acts as a highly potent, selective, reversible, and ATP-competitive inhibitor of GSK-3α/β (IC50 = 5 nM). Its specificity has been tested against various Cdk's (IC50 = 83, 300, 320, and 10,000 nM for Cdk5/p25, Cdk2/A, Cdk1/B, and Cdk4/D1, respectively) as well as many other commonly studied kinases (IC50 ≥ 10 µM), including MAP kinases, PKA, PKC isoforms, PKG, CK, and IRTK. Inhibition of GSK by BIO has been shown to result in the activation of Wnt-signaling pathway and sustained pluripotency in human and murine ESCs (embryonic stem cells). Reported to maintain self-renewal in human and mouse embryonic stem cells. Also induces the differentiation of neonatal cardiomyocytes. A 10 mM (500 µg/140 µl) solution of GSK-3 Inhibitor IX (Cat. No. 361552) in DMSO is also available. |
Catalogue Number | 361550 |
Brand Family | Calbiochem® |
Synonyms | BIO, (2ʹZ,3ʹE)-6-Bromoindirubin-3ʹ-oxime |
Product Information | |
---|---|
CAS number | 667463-62-9 |
ATP Competitive | Y |
Form | Purple solid |
Hill Formula | C₁₆H₁₀BrN₃O₂ |
Chemical formula | C₁₆H₁₀BrN₃O₂ |
Reversible | Y |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | GSK-3α/β |
Primary Target IC<sub>50</sub> | 5 nM against GSK-3α/β |
Purity | ≥97% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information | |
---|---|
R Phrase | R: 20/21/22 Harmful by inhalation, in contact with skin and if swallowed. |
S Phrase | S: 22-36/37 Do not breathe dust. Wear suitable protective clothing and gloves. |
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
361550-10MGCN | 04055977214079 |
361550-1MGCN | 04055977214062 |
361550-30MGCN | 04055977214086 |
Documentation
GSK-3 Inhibitor IX - CAS 667463-62-9 - Calbiochem SDS
Title |
---|
GSK-3 Inhibitor IX - CAS 667463-62-9 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
361550 |
References
Reference overview |
---|
Tseng, A-S., et al. 2006. Chem. Biol. 13, 957. Polychronopoulos, P., et al. 2004. J. Med. Chem. 47, 935. Sato, N., et al. 2004. Nat. Med. 10, 55. Meijer, L., et al. 2003. Chem. Biol. 10, 1255. |
Citations
Title | |
---|---|
|